Detailed Information on Publication Record
2017
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction
PÁVKOVÁ GOLDBERGOVÁ, Monika, Jiří JARKOVSKÝ, Jolana LIPKOVÁ, Simona LITTNEROVÁ, Martin POLOCZEK et. al.Basic information
Original name
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction
Authors
PÁVKOVÁ GOLDBERGOVÁ, Monika (203 Czech Republic, guarantor, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jolana LIPKOVÁ (203 Czech Republic, belonging to the institution), Simona LITTNEROVÁ (203 Czech Republic, belonging to the institution), Martin POLOCZEK (203 Czech Republic, belonging to the institution), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), Lenka KUBKOVÁ (203 Czech Republic, belonging to the institution), Krystyna KLUZ (203 Czech Republic, belonging to the institution), Petr KALA (203 Czech Republic, belonging to the institution), Jan MAŇOUŠEK (203 Czech Republic, belonging to the institution), Anna VAŠKŮ (203 Czech Republic, belonging to the institution) and Jiří PAŘENICA (203 Czech Republic, belonging to the institution)
Edition
Journal of Applied Genetics, Heidelberg, Springer, 2017, 1234-1983
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30400 3.4 Medical biotechnology
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.756
RIV identification code
RIV/00216224:14110/17:00096767
Organization unit
Faculty of Medicine
UT WoS
000405693600005
Keywords in English
MMP; Polymorphism; Prognosis; STEMI; TIMP
Tags
Tags
International impact, Reviewed
Změněno: 8/2/2021 15:04, Mgr. Tereza Miškechová
Abstract
V originále
The influence of polymorphisms in the large group of MMP and TIMP genes on clinical outcomes in patients after ST elevation myocardial infarction (STEMI) treated with primary PCI was analysed. In total, 550 consecutive Caucasian patients with STEMI were included in the present study, with a median of 32 months. We analysed 19 polymorphisms in the genes coding MMP and TIMP genes. The MMP-1 -519A/G and -422A/T polymorphisms are associated with combined endpoint after myocardial infarction. The hazard ratio for AT variant of MMP-1 -422A/T was 1.75 (p < 0.001); the variants with at least one A allele of MMP-1 -519A/G have less risk of combined endpoint. The TT variants of -1562C/T MMP-9 and at least one T allele of +92C/T MMP-13 were considered in a trend to affect disease progression and long-term survival after myocardial infarction. According to reclassification analysis NRI and IDI, long-term risk stratification using MMP-1 -422A/T and -519A/G polymorphisms gives additional information to the commonly used GRACE risk score. Patient stratification after myocardial infraction (MI) according to risk genotypes of MMP-1 polymorphisms could have important clinical implications for identification of patients at risk and therapeutic strategies.
Links
LM2015090, research and development project |
|